Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral promidone for acute ST-segment elevation myocardial infarction
ChiCTR2500113389Phase 2Completed
- Sponsor
- The First College of Clinical Medical Science, China Three Gorges University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of primidone in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by The First College of Clinical Medical Science, China Three Gorges University. Primary endpoint: Incidence of major adverse cardiovascular events at 3 months. Started Nov 2025; status: completed.
02
Drugs
primidone
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ChiCTR2500113389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113389.